External Urine Management Products Market size was more than USD 609.95 million in 2026 and is set to grow at a 5.04% CAGR between 2027 and 2036, surpassing USD 997.34 million by 2036. The industry revenue for 2027 is estimated at USD 635.81 million.
The growing elderly population is creating sustained demand in the external urine management products market because age-related changes and chronic health conditions can increase the occurrence of urinary incontinence and bladder dysfunction. Older individuals may experience weakened bladder control, reduced mobility, or conditions that make conventional toileting more difficult, increasing the need for practical urine management solutions. External products can support routine continence care while reducing the need for invasive urinary drainage in appropriate patients, making them relevant in home care, clinical, and institutional environments. Increasing demand for products that provide reliable urine collection, support patient dignity, and simplify caregiver responsibilities is encouraging broader use among aging populations.
Greater awareness of urinary incontinence and structured continence management is helping the external urine management products market expand as patients, caregivers, and healthcare professionals become more informed about available management options. Improved recognition of bladder control problems can encourage individuals to seek professional guidance rather than treating symptoms without appropriate support. Healthcare programs focused on continence assessment, hygiene, skin protection, and individualized urinary management can also introduce external collection products as part of broader care plans. As healthcare providers emphasize patient comfort, infection-conscious practices, and appropriate product selection, awareness of external urine management options can increase across hospitals, residential care environments, and home-based care.
Expansion of hospitals and long-term care facilities is creating additional points of demand for external urine collection and continence management solutions, supporting the external urine management products market growth. Healthcare institutions require products that can accommodate patients with temporary or persistent urinary management needs, including individuals with limited mobility, postoperative recovery requirements, or chronic bladder dysfunction. Long-term care facilities have an especially important role because residents may require ongoing continence support and assistance from caregivers. Broader healthcare capacity, combined with increasing attention to patient hygiene and efficient routine care, is encouraging institutional procurement of external urine management products suited to different patient needs and care environments.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising geriatric population driving higher incidence of urinary incontinence and bladder dysfunction | 2.20% | High | North America, Europe | High | Near Term |
| Increasing healthcare awareness and continence management programs supporting product adoption | 1.80% | High | North America, Asia Pacific | Medium | Mid Term |
| Expanding hospital care infrastructure and long-term care facilities boosting product demand | 1.60% | Moderate | North America, Europe, Asia Pacific | High | Mid Term |
In the external urine management products market, North America held the largest share of 42.08% in 2026, reflecting strong adoption of non-invasive urinary care solutions across hospitals, long-term care facilities, home healthcare, and outpatient environments. The region's mature healthcare system supports widespread use of products that can improve patient comfort while reducing reliance on invasive urinary management approaches. Rising demand for home-based care, an aging population, and increasing attention to infection prevention and patient dignity are important contributors to regional demand. Established reimbursement practices, healthcare professional awareness, and broad availability of continence care products further support North America's leading position.
Asia Pacific represents the fastest-growing regional market as healthcare systems increasingly prioritize patient-centered urinary care and less invasive management approaches. Expanding hospital networks, improving access to home healthcare, and rising awareness of continence management are creating favorable conditions for external urine management products. Demographic aging is also increasing the need for convenient solutions for patients with mobility limitations or chronic urinary challenges. As healthcare expenditure rises and caregivers become more receptive to products that support hygiene, comfort, and independent care, adoption is gaining momentum across both institutional and home settings.
The U.S. market emphasizes external urine management products that reduce catheter-associated complications and improve patient comfort across hospitals and long-term care settings. Healthcare providers in the U.S. increasingly integrate non-invasive continence solutions into infection prevention and patient mobility protocols.
Japan's aging population supports sustained demand for external urine management products in hospitals, nursing homes, and home care environments. Healthcare providers in Japan increasingly seek comfortable and discreet solutions that preserve patient dignity while simplifying daily continence management.
South Korea is expanding the use of external urine management products as healthcare facilities strengthen infection control and patient-centered care practices. Demand in South Korea favors user-friendly designs that improve comfort while reducing clinical workload in acute care settings.
Germany prioritizes external urine management products that support evidence-based continence care and reduce unnecessary catheter use. Hospitals and rehabilitation facilities in Germany continue to adopt products that improve patient outcomes while enhancing caregiver efficiency.
France encourages wider adoption of external urine management products as part of strategies to minimize invasive urinary management procedures. Healthcare providers in France increasingly value products that support patient comfort, skin protection, and efficient nursing care across clinical settings.
Italy is strengthening the use of external urine management products in elderly care and rehabilitation facilities where prolonged continence management is common. Healthcare institutions in Italy increasingly prefer practical, reliable products that improve hygiene while supporting patient mobility.
The offline segment accounted for the largest share of the external urine management products market at 59.96% in 2026. Its leading position reflects the continued importance of hospitals, pharmacies, medical supply outlets, and other physical healthcare channels for products that often require professional guidance and dependable availability. Healthcare providers and caregivers can evaluate product suitability, sizing, and usage requirements through established distribution networks, supporting purchasing confidence. The accessibility of offline channels for immediate medical product procurement further reinforces their role across institutional and homecare settings.
Online distribution is expected to grow at the fastest pace as consumers and caregivers increasingly value convenient access to healthcare products from home. Digital channels provide broader product visibility and enable users to compare different external urine management solutions without relying exclusively on nearby physical outlets. Discreet purchasing and home delivery can be particularly relevant for products associated with personal urinary care, while expanding digital healthcare purchasing habits are further supporting the shift toward online channels.
The male external catheters segment held the largest share of the external urine management products market at 63.11% in 2026. Its established position is supported by widespread use of external urine collection solutions for men who require urinary management without invasive catheterization. These products can offer greater convenience and support home-based care while reducing the need for insertion-based approaches. Increasing emphasis on patient comfort, hygiene, and practical long-term urinary management continues to sustain demand for male external catheter solutions.
The female external catheters segment is projected to achieve the fastest growth, supported by increasing awareness and adoption of non-invasive urinary management options designed specifically for female anatomy. Greater attention to gender-specific healthcare needs is encouraging the development and adoption of products that improve comfort, usability, and independence in urinary care. Expanding homecare practices and demand for alternatives to invasive catheterization are also creating favorable conditions for broader utilization of female external catheter products.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Distribution Channel | Online, Offline | Offline | Online |
| Product | Male External Catheters, Female External Catheters, Urine Collection Accessories | Male External Catheters | Female External Catheters |
| End-use | Hospitals, Clinics, Home Care Settings, Others | Hospitals | Home Care Settings |
1. Coloplast A/S (Denmark)
2. Hollister Incorporated (US)
3. Becton Dickinson and Company (US)
4. ConvaTec Group plc (UK)
5. Cardinal Health Inc. (US)
6. Teleflex Incorporated (US)
7. B. Braun Melsungen AG (Germany)
8. Stryker Corporation (US)
9. Medtronic plc (Ireland)
10. Wellspect HealthCare (Sweden)
Increasing focus on non-invasive patient care is driving innovation in the external urine management products market. Manufacturers are developing skin-friendly materials, improved fluid management technologies, and user-centered designs that enhance patient comfort while reducing healthcare-associated complications.
| Company Name | Date | Key Development |
|---|---|---|
| Hollister Inc. | 2024 | Hollister Inc. expanded production capacity for external catheter products in North America, strengthening its manufacturing footprint in the external urine management segment. The expansion is aimed at improving supply availability and supporting increasing demand for continence care products across hospital and home healthcare channels. |
| Teleflex Inc. | 2023 | Teleflex Inc. introduced upgraded silicone-based external urine management systems designed to enhance leakage protection and overall device performance. The product enhancement strengthens its position in continence care solutions by improving clinical usability and reliability in external urinary management applications. |
| BD (C. R. Bard) | 2025 | BD (C. R. Bard) launched advanced female external catheter products for intensive care applications, expanding its external urine management portfolio. The development enhances product coverage across female patient segments in clinical settings, supporting broader adoption of non-invasive urinary management solutions in acute care environments. |
| Coloplast Corp. | 2024 | Coloplast Corp. expanded home healthcare distribution partnerships across Europe and Asia-Pacific, strengthening its external urine management product reach. The initiative enhances multi-regional access to continence care solutions and supports broader adoption of home-based urinary management products across aging and mobility-impaired patient populations. |
| Consure Medical | 2025 | Consure Medical introduced a portable wearable urine collection technology for mobility-impaired patients, expanding its external urine management portfolio. The innovation supports non-invasive, mobile continence care and enhances patient mobility while addressing infection and leakage challenges in long-term care settings. |